ArticleLeukemia2018
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.
P Garrido Castro et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it